Patents-Review.com
🔗 Permalink
Assignee profile:

PharmAkea, Inc.

City:

San Diego, California

Country:

United States

Published Applications:

20

Last publication date:

2024-12-19

Patent Grants:

19

Last grant date:

2022-10-04

Top Inventors for applications by PharmAkea, Inc.

These are the the leading inventors for applications assigned to PharmAkea, Inc.:

Recent patent applications by PharmAkea, Inc.

PharmAkea, Inc. based in San Diego, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-12-19
US20240415824A1
Human necessities

USES OF A LYSYL OXIDASE-LIKE 2 INHIBITOR

 #2 | 2020-11-19 ✅ Patent 11,459,309 granted on 2022-10-04
US20200361901A1
Chemistry; metallurgy

Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making

 #3 | 2020-04-16 ✅ Patent 11,072,585 granted on 2021-07-27
US20200115341A1
Chemistry; metallurgy

Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof

 #4 | 2020-02-13 ✅ Patent 11,345,676 granted on 2022-05-31
US20200048218A1
Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds

 #5 | 2020-01-23 ✅ Patent 11,058,676 granted on 2021-07-13
US20200022972A1
Human necessities

Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof

 #6 | 2019-07-04 ✅ Patent 10,774,069 granted on 2020-09-15
US20190202805A1
Chemistry; metallurgy

Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making

 #7 | 2019-06-27 ✅ Patent 11,793,797 granted on 2023-10-24
US20190192495A1
Human necessities

Uses of a lysyl oxidase-like 2 inhibitor

 #8 | 2019-04-25 ✅ Patent 10,570,094 granted on 2020-02-25
US20190119211A1
Chemistry; metallurgy

Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof

 #9 | 2019-02-14 ✅ Patent 10,588,900 granted on 2020-03-17
US20190046520A1
Human necessities

Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof

 #10 | 2018-05-31 ✅ Patent 10,632,104 granted on 2020-04-28
US20180147185A1
Human necessities

Autotaxin inhibitors and uses thereof

 #11 | 2018-03-01 ✅ Patent 10,766,860 granted on 2020-09-08
US20180057458A1
Chemistry; metallurgy

Lysyl oxidase-like 2 inhibitors and uses thereof

 #12 | 2017-12-28 ✅ Patent 10,150,732 granted on 2018-12-11
US20170369443A1
Chemistry; metallurgy

Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof

 #13 | 2016-12-29 ✅ Patent 9,999,615 granted on 2018-06-19
US20160374991A1
Human necessities

Autotaxin inhibitor compounds

 #14 | 2016-09-15 ✅ Patent 9,926,318 granted on 2018-03-27
US20160264575A1
Chemistry; metallurgy

Tetracyclic autotaxin inhibitors

 #15 | 2016-08-18 ✅ Patent 9,468,628 granted on 2016-10-18
US20160235713A1
Human necessities

Autotaxin inhibitor compounds

 #16 | 2016-08-11 ✅ Patent 9,951,026 granted on 2018-04-24
US20160229809A1
Chemistry; metallurgy

Heterocyclic vinyl autotaxin inhibitor compounds

 #17 | 2016-08-04 ✅ Patent 9,714,240 granted on 2017-07-25
US20160222000A1
Chemistry; metallurgy

Vinyl autotaxin inhibitor compounds

 #18 | 2016-07-28 ✅ Patent 9,850,203 granted on 2017-12-26
US20160214935A1
Chemistry; metallurgy

Autotaxin inhibitor compounds

 #19 | 2016-02-18 ✅ Patent 9,334,261 granted on 2016-05-10
US20160046614A1
Chemistry; metallurgy

Autotaxin inhibitor compounds

 #20 | 2015-06-09 ✅ Patent 9,051,320 granted on 2015-06-09
US14462459
Chemistry; metallurgy

Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor

Also check out PHARMAKEA, INC.'s (San Diego, United States) applicant profile with 20 patent applications submitted.

AssigneeID:

135519 ⎘